AFA
EW icon

Abacus FCF Advisors’s Edwards Lifesciences EW Stock Holding History

Abacus FCF Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,072
Closed -$1.69M – 158
2020
Q4 		$1.69M Sell
19,072
-1,785
-9% -$148K 0.98% 63
2020
Q3 		$1.75M Buy
20,857
+7,497
+56% +$585K 0.94% 68
2020
Q2 		$924K Sell
13,360
-593
-4% -$42.1K 0.88% 72
2020
Q1 		$921K Sell
13,953
-1,404
-9% -$101K 1.05% 59
2019
Q4 		$1.2M Buy
+15,357
New +$1.2M 0.95% 81

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Abacus FCF Advisors's EW Position: Q1 2021 in Review

Abacus FCF Advisors sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 19,072 shares — an estimated $1.69M sold.

Abacus FCF Advisors first reported a position in EW in Q4 2019 and held it in 5 quarters. The position peaked at $1.75M in Q3 2020. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.

  • Abacus FCF Advisors reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
  • Abacus FCF Advisors sold 19,072 Edwards Lifesciences shares in Q1 2021, an estimated $1.69M.
  • Abacus FCF Advisors first reported a position in Edwards Lifesciences in Q4 2019 and held it in 5 quarters.
  • Abacus FCF Advisors's Edwards Lifesciences position peaked at $1.75M in Q3 2020.
  • 1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on Abacus FCF Advisors's 13F filing for Q1 2021, filed 6 Apr 2021.